Elbit Medical Services of Israel and Dr Reddy's Group of India have announced the formation of a joint venture, Elbit International Medical Center. Dr Reddy's Group is a manufacturer of bulk drugs and exports penicillin, while Elbit Medical Services is a division of the Haifa-based Elbit Holding Group and operates about 30 medical centers worldwide.
The new venture will set up a chain of medical centers equipped with a range of diagnostic and therapeutic equipment. The first center, to be set up at a cost of $6 million, will open in the southern Indian city of Bangalore under the name of Elbit Diagnostic. The company will invest $80 million over the next three years in similar projects.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze